Evidence map›Paper›PMID 2062658›Full record

ArticleNucleic acids research1991

Oligonucleotide inhibition of IL2R alpha mRNA transcription by promoter region collinear triplex formation in lymphocytes.

F M Orson, D W Thomas, W M McShan, D J Kessler, M E Hogan

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 180 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Unambiguous demonstration of triple-helix-directed gene modification.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Accessibility of nuclear DNA to triplex-forming oligonucleotides: the integrated HIV-1 provirus as a target.Proceedings of the National Academy of Sciences of the United States of America · 1997
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Antisense oncogene and tumor suppressor gene therapy of cancer.Journal of molecular medicine (Berlin, Germany) · 1996
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

F M OrsonVeterans Affairs Medical Center, Houston, TX 77030.
D W Thomas
W M McShan
D J Kessler
M E Hogan
Baylor College of Medicine · US

Funding

INTERLEUKIN 2 RECEPTORS IN AGINGR01AG007068 · NIA · BAYLOR COLLEGE OF MEDICINE · PI ORSON, FRANK M · 1987 to 1989
–
MONOCYTE HIV 1 INFECTION AND NEUROLOGICAL FUNCTIONR01AI028071 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI ROSSEN, ROGER D · 1989 to 1993
–
NIAID NIH HHS AI28071NIA NIH HHS AGO7068
6 · The paper itself

Abstract

The promoter region of the IL2R alpha gene 5' flanking sequence contains enhancer elements crucial for binding nuclear factors which upregulate transcription following T lymphocyte activation. A 3' exonuclease resistant oligonucleotide (3'A-IL28p, terminated by a free amine group at its 3' end) was designed to bind to the IL2R alpha promoter region from -273 to -246, forming a collinear triplex spanning the kappa B enhancer (-266 to -256) as well as most of the serum response element (CArG box, -251 to -244). The binding site specificity of this oligonucleotide was demonstrated in electrophoretic mobility shift assays and by inhibition of restriction endonuclease (HinfI) cleavage within the segment of the target DNA predicted to form a triplex with the oligonucleotide. Intact normal lymphocytes, preincubated for 2h with 3'A-IL28p, accumulated less IL2Ralpha mRNA relative to other mRNAs (c-myc, beta-actin, IL2R beta, IL-6) for up to 12h after PHA stimulation, than did lymphocytes treated with a control oligomer of similar composition but different sequence. Nuclear run-on studies demonstrated that the rate of IL2R alpha mRNA synthesis relative to c-myc and beta-actin was also selectively diminished by treatment with 3'A-IL28p. These experiments suggest that transcription of individual genes can be selectively modulated in living cells by sequence specific collinear triplex formation in regulatory enhancer sequences.

Indexed as

Base SequenceBinding SitesCells, CulturedHumansKineticsLymphocyte ActivationLymphocytesMolecular Sequence DataOligodeoxyribonucleotidesPromoter Regions, GeneticReceptors, Interleukin-2Transcription, GeneticOligodeoxyribonucleotidesReceptors, Interleukin-2

Identifiers

PMID2062658
PMCPMC328345
OpenAlexW2061419481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.